Phase 1 Inflammatory Conditions Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Completed
Phase 1
A study of the safety and tolerability of single doses of wafers containing cannabidiol (CBD) that dissolve under the tongue compared to CBD oil that is swallowed in healthy volunteers.
PainInsomniaAnxiety+2 more
iX Biopharma Pty Ltd12 enrolled1 locationACTRN12620000891921
Not Yet Recruiting
Phase 1
A Phase 1, Randomised, Double-Blind, placebo controlled, single and multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of KZR-616 in healthy female subjects.
Autoimmune disorders for example systemic lupus erythematosusChronic inflammatory conditions for example rheumatoid arthritis
Clinical Netwprk Services72 enrolled1 locationACTRN12618002060224
Completed
Phase 1
A Randomized, Single-blind, Single-dose, 3-arm, Parallel Group Study to Determine the Pharmacokinetic Similarity of ABP 710 and Infliximab (Remicade 'Registered Trademark') in Healthy Adult Subjects
Infliximab is currently used to treat patients with adult and pediatric inflammatory conditions. These inflammatory conditions affects various body systems such as gastrointestinal (Crohn’s disease).
Amgen Inc, USA.150 enrolled2 locationsACTRN12614000903684